Changes in physical activity, sedentary behavior, and self-reported cognitive function in cancer survivors before and during the COVID-19 pandemic: A cross-sectional study.
Cancer survivorship
Cancer-related cognitive impairment
Exercise
Sedentary time
Journal
Journal of sport and health science
ISSN: 2213-2961
Titre abrégé: J Sport Health Sci
Pays: China
ID NLM: 101606001
Informations de publication
Date de publication:
11 2023
11 2023
Historique:
received:
19
11
2022
revised:
23
02
2023
accepted:
10
04
2023
medline:
6
11
2023
pubmed:
7
6
2023
entrez:
6
6
2023
Statut:
ppublish
Résumé
Physical activity (PA) and reductions in sedentary behavior (SED) may mitigate cancer-related cognitive impairment. The purpose of this study was to examine (a) the associations between changes in PA, SED, and cognitive function in cancer survivors before and during the coronavirus disease 2019 (COVID-19) pandemic; and (b) clinical subgroups that moderate this association. A cross-sectional survey was administered online to adult cancer survivors globally between July and November of 2020. This was a secondary analysis of a cross-sectional survey examining changes in self-reported PA and quality of life in cancer survivors before and during the COVID-19 pandemic. Self-reported Questionnaires assessed moderate-to-vigorous PA (MVPA) using the modified Godin Leisure Time Exercise Questionnaire, cognitive function using the Functional Assessment of Cancer Therapy-Cognitive Function (FACT-Cog) scale, and SED using the Domain-specific Sitting Time questionnaire. Cancer survivors were classified into no change in behavior, desirable change (i.e., increase MVPA to meet PA guidelines or decrease SED by ≥60 min/day), and undesirable change (i.e., decrease MVPA to <150 min/week or increase SED by ≥60 min/day). Analysis of covariance examined differences in FACT-Cog scores across the activity change categories. Planned contrasts compared differences in FACT-Cog scores between cancer survivors with (a) no meaningful change vs. any change, and (b) a desirable change vs. an undesirable change. There were no significant differences in FACT-Cog scores across activity-change categories in the full sample of cancer survivors (n = 371; age = 48.6 ± 15.3 years (mean ± SD)). However, cancer survivors who were diagnosed ≥5 years ago (t(160) = -2.15, p = 0.03) or who received treatment ≥5 years ago (t(102) = -2.23, p = 0.03) and who had a desirable change in activity reported better perceived cognitive abilities than those who had an undesirable change. PA promotion efforts should consider reducing SED in addition to maintaining MVPA in long-term cancer survivors to mitigate cancer-related cognitive impairment during the COVID-19 pandemic.
Sections du résumé
BACKGROUND
Physical activity (PA) and reductions in sedentary behavior (SED) may mitigate cancer-related cognitive impairment. The purpose of this study was to examine (a) the associations between changes in PA, SED, and cognitive function in cancer survivors before and during the coronavirus disease 2019 (COVID-19) pandemic; and (b) clinical subgroups that moderate this association.
METHODS
A cross-sectional survey was administered online to adult cancer survivors globally between July and November of 2020. This was a secondary analysis of a cross-sectional survey examining changes in self-reported PA and quality of life in cancer survivors before and during the COVID-19 pandemic. Self-reported Questionnaires assessed moderate-to-vigorous PA (MVPA) using the modified Godin Leisure Time Exercise Questionnaire, cognitive function using the Functional Assessment of Cancer Therapy-Cognitive Function (FACT-Cog) scale, and SED using the Domain-specific Sitting Time questionnaire. Cancer survivors were classified into no change in behavior, desirable change (i.e., increase MVPA to meet PA guidelines or decrease SED by ≥60 min/day), and undesirable change (i.e., decrease MVPA to <150 min/week or increase SED by ≥60 min/day). Analysis of covariance examined differences in FACT-Cog scores across the activity change categories. Planned contrasts compared differences in FACT-Cog scores between cancer survivors with (a) no meaningful change vs. any change, and (b) a desirable change vs. an undesirable change.
RESULTS
There were no significant differences in FACT-Cog scores across activity-change categories in the full sample of cancer survivors (n = 371; age = 48.6 ± 15.3 years (mean ± SD)). However, cancer survivors who were diagnosed ≥5 years ago (t(160) = -2.15, p = 0.03) or who received treatment ≥5 years ago (t(102) = -2.23, p = 0.03) and who had a desirable change in activity reported better perceived cognitive abilities than those who had an undesirable change.
CONCLUSION
PA promotion efforts should consider reducing SED in addition to maintaining MVPA in long-term cancer survivors to mitigate cancer-related cognitive impairment during the COVID-19 pandemic.
Identifiants
pubmed: 37279854
pii: S2095-2546(23)00056-X
doi: 10.1016/j.jshs.2023.06.001
pmc: PMC10658308
pii:
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
653-663Informations de copyright
Copyright © 2023. Production and hosting by Elsevier B.V.
Références
J Cancer Surviv. 2023 Aug;17(4):1191-1201
pubmed: 35079964
BMC Med Res Methodol. 2015 Aug 12;15:60
pubmed: 26264621
Brain Cogn. 2005 Oct;59(1):60-70
pubmed: 15975700
Annu Rev Clin Psychol. 2018 May 7;14:425-451
pubmed: 29345974
Cancer Nurs. 2018 Jul/Aug;41(4):327-343
pubmed: 29194066
J Clin Oncol. 2010 Jan 10;28(2):340-7
pubmed: 19949016
Eur J Cancer Care (Engl). 2011 Jul;20(4):514-9
pubmed: 20597954
Cancer. 2013 Jun 1;119(11):1928-35
pubmed: 23504979
Phys Ther. 2020 Mar 10;100(3):523-542
pubmed: 32065236
J Clin Oncol. 2019 May 10;37(14):1154-1158
pubmed: 30920881
Breast Cancer Res Treat. 2013 Jan;137(2):617-30
pubmed: 23242613
Med Sci Sports Exerc. 2019 Nov;51(11):2375-2390
pubmed: 31626055
Ann Oncol. 2019 Dec 1;30(12):1925-1940
pubmed: 31617564
Breast Cancer Res Treat. 2017 Oct;165(3):699-707
pubmed: 28677009
Mayo Clin Proc. 2017 Mar;92(3):391-398
pubmed: 28185657
Can J Appl Sport Sci. 1985 Sep;10(3):141-6
pubmed: 4053261
Oncol Nurs Forum. 2012 Jan;39(1):E31-40
pubmed: 22201666
J Am Geriatr Soc. 2013 Mar;61(3):452-3
pubmed: 23496180
Cancer. 2018 Jan 1;124(1):192-202
pubmed: 28926676
J Clin Oncol. 2021 Oct 10;39(29):3283-3292
pubmed: 34406822
Cancer Med. 2020 May;9(10):3417-3424
pubmed: 32202706
J Natl Cancer Inst. 2020 Feb 1;112(2):123-127
pubmed: 31504664
Int J Behav Nutr Phys Act. 2017 Jun 10;14(1):75
pubmed: 28599680
Ann Oncol. 2020 May;31(5):650-658
pubmed: 32321669
Psychol Sport Exerc. 2020 Sep;50:
pubmed: 32831643
J Behav Med. 2021 Apr;44(2):277-283
pubmed: 33185782
Cancer Epidemiol Biomarkers Prev. 2010 Nov;19(11):2691-709
pubmed: 20833969
CA Cancer J Clin. 2022 May;72(3):230-262
pubmed: 35294043
Front Psychol. 2020 Aug 24;11:2033
pubmed: 32982846
Biomed Res Int. 2016;2016:1820954
pubmed: 27144158
J Pain Symptom Manage. 2020 Nov;60(5):e25-e34
pubmed: 32889039
Cancer. 2004 Jun 1;100(11):2292-9
pubmed: 15160331
Breast Cancer Res Treat. 2008 Jul;110(1):143-52
pubmed: 17674194
Br J Sports Med. 2017 May;51(10):800-811
pubmed: 27153869
JMIR Cancer. 2021 Feb 3;7(1):e25317
pubmed: 33471776
Psychooncology. 2021 Aug;30(8):1262-1277
pubmed: 33866625
Am J Epidemiol. 2018 Mar 1;187(3):441-454
pubmed: 28992036
Sci Rep. 2019 Feb 28;9(1):2851
pubmed: 30820029
Support Care Cancer. 2019 Apr;27(4):1435-1441
pubmed: 30225570
Psychooncology. 2014 Oct;23(10):1133-41
pubmed: 24700645
Aging Clin Exp Res. 2020 Jun;32(6):969-984
pubmed: 32026419
Support Care Cancer. 2017 Nov;25(11):3551-3559
pubmed: 28639097
J Behav Med. 2017 Apr;40(2):332-342
pubmed: 27586134
Cancer Causes Control. 2016 Jan;27(1):59-68
pubmed: 26518196
J Cancer Surviv. 2009 Dec;3(4):223-32
pubmed: 19760150
J Gerontol A Biol Sci Med Sci. 2016 Jan;71(1):78-83
pubmed: 26273024
J Clin Med. 2022 Mar 12;11(6):
pubmed: 35329894
Med Sci Sports Exerc. 2010 Jun;42(6):1094-102
pubmed: 19997030
Psychooncology. 2018 Feb;27(2):687-690
pubmed: 28414894
J Pain Symptom Manage. 2009 Jun;37(6):982-95
pubmed: 19500722
Psychol Methods. 2012 Sep;17(3):437-55
pubmed: 22506584
BMC Cancer. 2018 Jun 25;18(1):685
pubmed: 29940894
PLoS One. 2013;8(3):e57598
pubmed: 23483916
Cancer Causes Control. 2011 Aug;22(8):1111-20
pubmed: 21656163
Prev Med. 2021 Apr;145:106415
pubmed: 33400938
JCO Oncol Pract. 2020 Oct;16(10):656-664
pubmed: 32603253
J Phys Act Health. 2013 Mar;10(3):350-8
pubmed: 22820125
Psychooncology. 2021 May;30(5):635-648
pubmed: 33533166
Cancer Treat Rev. 2013 May;39(3):297-304
pubmed: 23219452
Med Sci Sports Exerc. 2019 Nov;51(11):2391-2402
pubmed: 31626056
BMC Med Res Methodol. 2014 Mar 25;14:42
pubmed: 24669751
Exp Gerontol. 2022 Mar;159:111698
pubmed: 35026335
Cancer Causes Control. 2022 Jul;33(7):939-950
pubmed: 35554777
J Pain Symptom Manage. 2015 Apr;49(4):697-706
pubmed: 25240787
JAMA Oncol. 2022 Mar 01;8(3):395-403
pubmed: 34989765
Psychooncology. 2010 Dec;19(12):1321-8
pubmed: 20127909
Lancet Oncol. 2011 Jul;12(7):703-8
pubmed: 21354373
Am J Clin Nutr. 2012 Feb;95(2):437-45
pubmed: 22218159
PLoS One. 2017 Aug 14;12(8):e0182554
pubmed: 28806753